Free Trial

Boston Scientific (BSX) Competitors

Boston Scientific logo
$96.83 -0.49 (-0.50%)
As of 03:38 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

BSX vs. ALGN, HOLX, HQY, MMSI, AMN, CAH, DVA, ECL, HCA, and MDT

Should you be buying Boston Scientific stock or one of its competitors? The main competitors of Boston Scientific include Align Technology (ALGN), Hologic (HOLX), HealthEquity (HQY), Merit Medical Systems (MMSI), AMN Healthcare Services (AMN), Cardinal Health (CAH), DaVita (DVA), Ecolab (ECL), HCA Healthcare (HCA), and Medtronic (MDT).

Boston Scientific vs. Its Competitors

Align Technology (NASDAQ:ALGN) and Boston Scientific (NYSE:BSX) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, media sentiment, analyst recommendations, profitability, institutional ownership and risk.

Align Technology has a beta of 1.7, meaning that its share price is 70% more volatile than the S&P 500. Comparatively, Boston Scientific has a beta of 0.61, meaning that its share price is 39% less volatile than the S&P 500.

Align Technology currently has a consensus target price of $215.00, suggesting a potential upside of 64.52%. Boston Scientific has a consensus target price of $120.79, suggesting a potential upside of 24.74%. Given Align Technology's higher possible upside, research analysts plainly believe Align Technology is more favorable than Boston Scientific.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Align Technology
1 Sell rating(s)
7 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.53
Boston Scientific
0 Sell rating(s)
2 Hold rating(s)
23 Buy rating(s)
2 Strong Buy rating(s)
3.00

Boston Scientific has a net margin of 13.55% compared to Align Technology's net margin of 11.04%. Boston Scientific's return on equity of 19.21% beat Align Technology's return on equity.

Company Net Margins Return on Equity Return on Assets
Align Technology11.04% 13.36% 8.32%
Boston Scientific 13.55%19.21%10.62%

88.4% of Align Technology shares are held by institutional investors. Comparatively, 89.1% of Boston Scientific shares are held by institutional investors. 0.7% of Align Technology shares are held by company insiders. Comparatively, 0.5% of Boston Scientific shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Boston Scientific had 65 more articles in the media than Align Technology. MarketBeat recorded 83 mentions for Boston Scientific and 18 mentions for Align Technology. Boston Scientific's average media sentiment score of 0.96 beat Align Technology's score of 0.76 indicating that Boston Scientific is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Align Technology
9 Very Positive mention(s)
0 Positive mention(s)
8 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Boston Scientific
45 Very Positive mention(s)
5 Positive mention(s)
15 Neutral mention(s)
2 Negative mention(s)
1 Very Negative mention(s)
Positive

Boston Scientific has higher revenue and earnings than Align Technology. Align Technology is trading at a lower price-to-earnings ratio than Boston Scientific, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Align Technology$4.00B2.37$421.36M$5.9322.04
Boston Scientific$16.75B8.57$1.85B$1.6857.64

Summary

Boston Scientific beats Align Technology on 13 of the 17 factors compared between the two stocks.

Get Boston Scientific News Delivered to You Automatically

Sign up to receive the latest news and ratings for BSX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BSX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BSX vs. The Competition

MetricBoston ScientificMED PRODUCTS IndustryMedical SectorNYSE Exchange
Market Cap$143.48B$10.56B$6.10B$22.14B
Dividend YieldN/A1.84%5.64%3.55%
P/E Ratio57.6422.1985.7030.04
Price / Sales8.5735.18527.9869.64
Price / Cash26.6625.6126.3018.34
Price / Book6.493.4812.894.66
Net Income$1.85B$210.63M$3.30B$1.01B
7 Day Performance-0.06%2.30%4.68%1.33%
1 Month Performance-9.62%2.06%7.99%3.33%
1 Year Performance14.54%-6.89%75.79%14.24%

Boston Scientific Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BSX
Boston Scientific
4.9254 of 5 stars
$96.83
-0.5%
$120.79
+24.7%
+15.1%$143.48B$16.75B57.6453,000Analyst Downgrade
Analyst Revision
ALGN
Align Technology
4.8608 of 5 stars
$126.37
+0.1%
$215.00
+70.1%
-45.2%$9.16B$4.00B21.3120,945
HOLX
Hologic
4.7985 of 5 stars
$67.15
-0.1%
$79.38
+18.2%
-15.0%$14.94B$4.03B27.867,063
HQY
HealthEquity
4.4092 of 5 stars
$95.34
-1.2%
$119.77
+25.6%
+6.6%$8.21B$1.20B57.783,120
MMSI
Merit Medical Systems
4.7022 of 5 stars
$80.86
+0.8%
$107.50
+32.9%
-11.9%$4.79B$1.36B41.057,400Positive News
AMN
AMN Healthcare Services
4.2558 of 5 stars
$18.51
-1.9%
$23.25
+25.6%
-46.6%$709.38M$2.98B-2.382,968Positive News
CAH
Cardinal Health
4.9354 of 5 stars
$154.79
+0.7%
$165.93
+7.2%
+38.0%$36.77B$222.58B24.0057,700Positive News
Analyst Forecast
DVA
DaVita
4.7919 of 5 stars
$130.66
-0.1%
$158.00
+20.9%
-18.4%$9.34B$12.82B12.8576,000
ECL
Ecolab
4.8894 of 5 stars
$272.72
+0.6%
$292.00
+7.1%
+10.2%$77.35B$15.74B36.4148,000Positive News
Analyst Forecast
HCA
HCA Healthcare
4.7649 of 5 stars
$421.07
+0.5%
$407.75
-3.2%
+9.0%$98.53B$70.60B17.70316,000
MDT
Medtronic
4.8429 of 5 stars
$94.00
-0.2%
$102.27
+8.8%
+10.6%$120.57B$33.54B25.8995,000Positive News
Analyst Downgrade

Related Companies and Tools


This page (NYSE:BSX) was last updated on 10/6/2025 by MarketBeat.com Staff
From Our Partners